| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |